Cumulative use of therapeutic bladder anticholinergics and the risk of dementia in patients with lower urinary tract symptoms: a nationwide 12-year cohort study

doi:10.1186/s12877-019-1401-y

Chia Nan University of Pharmacy & Science Institutional Repository > 智慧生活學院 > 醫務管理系(所) > 期刊論文 > Item 310902800/32507

請使用永久網址來引用或連結此文件: https://ir.cnu.edu.tw/handle/310902800/32507

標題:	Cumulative use of therapeutic bladder anticholinergics and the risk of dementia in patients with lower urinary tract symptoms: a nationwide 12-year cohort study
作者:	Wang, Yi-Chi Chen, Yung-Liang Huang, Chun-Che Chung-Han Ho(何宗翰) Huang, Yu-Tung Wu, Ming-Ping Ou, Ming-Jung Yang, Chiu-Hsien Chen, Ping-Jen
貢獻者:	Kaohsiung Med Univ, Kaohsiung Municipal Hsiao Kang Hosp, Dept Family Med Kaohsiung Med Univ, Kaohsiung Municipal Ta Tung Hosp, Dept Family Med I Shou Univ, Coll Med, Dept Healthcare Adm Chi Mei Med Ctr, Dept Med Res Chia Nan Univ Pharm & Sci, Dept Hosp & Hlth Care Adm Chang Gung Mem Hosp, Ctr Big Data Analyt & Stat Chi Mei Fdn Hosp, Dept Obstet & Gynecol, Div Urogynecol Fu Jan Catholic Univ, Coll Med, Dept Obstet & Gynecol Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Family Med Kaohsiung Med Univ, Coll Med, Sch Med UCL, Marie Curie Palliat Care Res Dept, Div Psychiat Chi Mei Med Ctr, Palliat Care Ctr
關鍵字:	Anticholinergics Cohort study Cumulative defined daily doses Dementia Lower urinary tract symptoms
日期:	2019
上傳時間:	2020-07-29 13:47:49 (UTC+8)
出版者:	BMC
摘要:	Background: Studies have shown an association between lower urinary tract symptoms (LUTS) and an increased risk of dementia. Whether anticholinergic use contributes to the development of dementia in patients with LUTS remains unknown, especially in Asian populations. This study aims to investigate the association between anticholinergic use and dementia in patients with LUTS. Methods: This study included patients aged 50 years and over with newly diagnosed LUTS (January 2001 to December 2005), divided into four groups according to their cumulative defined daily doses (cDDDs) of anticholinergics: < 28 cDDDs, 28-84 cDDDs, 85-336 cDDDs, >= 337 cDDDs. Patients were followed up until dementia developed or until the end of 2012. Results: We recruited a total of 16,412 patients. The incidence of dementia was 10% in the < 28 cDDD group, 8.9% in the 28-84 cDDD group, 11.5% in the 85-336 cDDD group, and 14.4% in the >= 337 cDDD group (p =.005). In a Cox proportional hazards analysis, the adjusted hazard ratio of dementia was 1.15 (95% CI = 0.97-1.37) in the 85336 cDDD group, and 1.40 (95% CI = 1.12-1.75) in the >= 337 cDDD group after adjusting for covariates. Conclusions: Our study indicates that higher cumulative anticholinergic exposure is associated with an increase in the risk of incident dementia in patients with LUTS aged 50 years of age and over. Either using one anticholinergic agent or switching anticholinergic agents cumulatively increases this risk. Therapeutic risks and benefits of using anticholinergics in LUTS treatment should be clinically reviewed and weighed.
關聯:	Bmc Geriatrics, v.19, n.1, pp.380
顯示於類別:	[醫務管理系(所)] 期刊論文

文件中的檔案:

檔案	描述	大小	格式	瀏覽次數
10.1186-s12877-019-1401-y.pdf		765Kb	Adobe PDF	435	檢視/開啟
index.html		0Kb	HTML	1507	檢視/開啟

在CNU IR中所有的資料項目都受到原著作權保護.

TAIR相關文章

資料載入中.....